Importance The use of sacubitril/valsartan is not endorsed by practice guidelines for use in
patients with New York Heart Association class IV heart failure with a reduced ejection …

Background— Endomyocardial biopsy (EMB) is often considered when the pathogenesis of
heart failure cannot be determined by noninvasive testing. Uncertainty remains about the …

Cardiogenic shock remains a challenging disease entity and is associated with significant
morbidity and mortality. Temporary mechanical circulatory support (MCS) can be implemented …

Objectives : This study sought to determine the efficacy and safety of a novel, pH-neutral
formulation of furosemide administered subcutaneously (SC) for treatment of acute …

Background Thromboembolism is a life-threatening manifestation of coronavirus disease
2019 (COVID-19). We investigated a dysfunctional phenotype of vascular endothelial cells in …

Background: Heart failure (HF) prevalence in arrhythmogenic right ventricular
cardiomyopathy/dysplasia (ARVC/D) varies depending on study cohort and is not well characterized. …

Aims Desmoplakin (DSP) cardiomyopathy is an increasingly recognized form of arrhythmogenic
cardiomyopathy. With a genotype-specific approach, we characterized the diagnosis, …

Myocarditis and myopericarditis may occur after COVID-19 vaccination with an incidence of
two to twenty cases per 100,000 individuals, but underlying mechanisms related to disease …

The prevalence of sarcoidosis-related cardiomyopathy is increasing. Sarcoidosis impacts
cardiac function through granulomatous infiltration of the heart, resulting in conduction disease…

Inflammatory dilated cardiomyopathy (DCMi) is a major cause of heart failure in children
and young adults. DCMi develops in up to 30% of myocarditis patients, but the mechanisms …